The 40 Under 40 program, in its fourth year, honors the industry’s best-regarded young talent.
MM+M has announced its 40 Under 40 Class of 2023. The program, which debuted in 2020, shines the spotlight on the young marketers who are set to lead the industry well into the future.
This year’s 40 Under 40 honorees stem from a broad range of organizations across the health and wellness spectrum, including pharma and biotech companies, device and diagnostic manufacturers, medical marketing agencies and health media firms. At those organizations, the 2023 honorees hold roles that encompass creative, strategy, accounts and more.
“Among the many reasons the medical marketing business continues to thrive is the abundance of top-flight talent in its ranks. Other verticals are jealous, frankly,” said MM+M editor-in-chief Larry Dobrow. “While that makes the 40 Under 40 selection process a challenge, it’s one that we embrace. It’s a privilege to celebrate the individuals set to lead the business for years to come.”
The honorees will be celebrated at an event on February 16 in New York City.
Here is the complete 2023 class of MM+M’s 40 Under 40:
SVP, healthcare, public health and equity, Ketchum
Medical director, Merge
EVP and managing director, PrecisionXtract
Director of social media, MyHealthTeam
Chief content officer, Havas Health & You
Associate director of consumer digital marketing, Takeda
Head, portfolio marketing, Allergan Aesthetics
SVP, access and adherence, OptimizeRx
SVP, brand planning, Havas Life New York
VP, group director, data and analytics, SSCG Media Group
Chief marketing officer, Thorne HealthTech
CEO and cofounder, Eyes On Eyecare
Director, media, CMI Media Group
EVP, managing director, Healthcare Consultancy Group
Director, communications and public affairs leader, immunology, Janssen
Global head of content and media relations, CSL
VP, strategy and business development, GoodRx
SVP, creative director, Evoke Create
Director, HCP marketing — women’s cancers, Novartis
Chief marketing officer and head of growth, MediFind
Senior director, brand marketing lead, Myovant Sciences
Executive director, oncology patient marketing, Bayer
SVP, media strategy and integration, Klick Health
Director, client development and experience, GoodRx
VP, team leader, strategic solutions and chair of DE&I committee, Jumo Health
SVP, client solutions, ConnectiveRx
Brand director, U.S. hematology marketing, ADC Therapeutics
Managing director, Eversana
Executive director of account management, Dieste
Vertical marketing lead, pharma health and wellness, Roku
Associate director, U.S. ATIOLs, Alcon Laboratories
EVP and managing director, PrecisionValue
Director, market access strategy, payer and site of care marketing lead, Horizon Therapeutics
VP, marketing, Dotdash Meredith, Health Group
Senior director, men’s health marketing, Endo International
Director, U.S. commercial, content operations, GSK
Practice leader, media and engagement, Real Chemistry
EVP, director of experience design, Area 23
Director of sales, brand, Samsung Ads
Join MM+M and a who’s-who of health media experts at Convene Rockefeller 75 Rockefeller Plaza, NYC for a candid discussion of the industry’s most compelling issues.
Spherico, a division of GSW recently conducted a survey among payers to gain insight into their behaviors, identify trends and better understand what is impacting them day to day.
How a different kind of ad agency is putting clients first.
Patients are becoming more educated about their health conditions and potential treatment options and are now more engaged than ever on social media as they search, ask, engage, and advocate on these platforms.
The conference also highlighted the growing importance of behavioral health and underscored trends accelerated by the COVID-19 pandemic.
Create your free account or log in to continue reading this premium content.